We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
LH.MX

Price
5245.61
Stock movement up
+- (%)
Company name
Labcorp Holdings Inc.
Exchange
(MX
,
Currency
MXN
)
Sector
Healthcare >
Diagnostics & Research
Market cap
435.91B
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
27.91%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-31

DIVIDENDS

LH.MX does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open5245.61
Daily high5245.61
Daily low5245.61
Daily Volume0K
All-time high5559.07
1y analyst estimate-
Beta0.83
EPS (TTM)-
Dividend per share0.00
Ex-div date28 Aug 2025
Next earnings date5 Feb 2026

Downside potential

Loading...
Downside potential data
LH.MXS&P500
Current price drop from All-time high-5.64%-1.10%
Highest price drop-26.23%-19.00%
Date of highest drop17 Feb 20258 Apr 2025
Avg drop from high-15.49%-2.76%
Avg time to new high-5 days
Max time to new high267 days89 days
COMPANY DETAILS
LH.MX (Labcorp Holdings Inc.) company logo
Marketcap
435.91B
Marketcap category
Large-cap
Description
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governments, physician, large provider organizations, other healthcare providers, hospitals and health systems, patients and consumers, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
Employees
70000
Investor relations
-
CEO
Country
Mexico
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Even though Labcorp Holdings Inc. ( NYSE:LH ) posted strong earnings, investors appeared to be underwhelmed. We did...
November 7, 2025
Labcorp’s third quarter results met Wall Street’s revenue expectations, but the market responded negatively, reflecting investor concerns about profitability and future growth levers. Management attri...
November 4, 2025
OLATHE, Kan., November 03, 2025--KCAS Bio, a leading contract research organization (CRO) specializing in comprehensive bioanalytical and biomarker services, is delighted to announce the appointment o...
November 3, 2025
OPKO Health recently reported third-quarter earnings with revenue of US$151.67 million and net income of US$21.63 million, surpassing analyst expectations, and announced a collaboration with Regeneron...
October 31, 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
October 31, 2025
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...
October 31, 2025
Labcorp Holdings Inc (LH) reports a robust 9% revenue increase and a 19% rise in adjusted EPS, while navigating challenges in early development and currency impacts.
October 30, 2025
Labcorp Holdings (LH) posted a net profit margin of 6.2% for the period, up from 3.4% a year ago, as earnings surged 96.4% year-over-year. This is well above the company's five-year average despite a ...
October 30, 2025
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 8.6% year on year to $3.56 billion. Its non-GAAP profit of $4.18 per share ...
October 29, 2025
Shares of healthcare diagnostics company Labcorp Holdings (NYSE:LH) fell 3.8% in the morning session after the company's third-quarter results, while beating headline estimates, revealed a miss on a k...
October 28, 2025
Next page